Advisory Services Network, LLC Amicus Therapeutics, Inc. Transaction History

Advisory Services Network, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 24, 2021	SELL	$9.2 - $23.86 $0 - $0	0 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$13.47 - $24.89 $8,539 - $15,780	-634 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $8,172 - $10,074	634 New	634 $9,000
Q2 2020 Aug 10, 2020	SELL	$8.86 - $15.69 $5,307 - $9,398	-599 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$7.48 - $10.75 $4,480 - $6,439	599 New	599 $6,000
Q3 2018 Nov 02, 2018	SELL	$11.6 - $16.54 $1,009 - $1,438	-87 Closed	0 $0
Q3 2017 Oct 12, 2017	BUY	$11.74 - $15.78 $1,021 - $1,372	87	87 $1,000

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.79B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.